Drug makers seeking new growth engines

Published: 2013-01-29 06:59:00

Updated: 2013-01-29 06:59:00

Leading pharmaceutical companies here are scrambling to find new growth engines against a deteriorating business environment in the aftermath of the government’s forced price cut for drugs and other medical products covered by National Health Insurance.

Some have decided to increase research a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK